Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
CASU, GAVINO
ARMYDA-AMULET, NCT05554822: Head-to-head Comparison of Single Versus Dual Antiplatelet Treatment Strategy After Percutaneous Left Atrial Appendage Closure: a Multicenter, Randomized Study	Recruiting	3	574	Europe	Aspirin 100mg, Aspirin 100 mg OD plus clopidogrel 75 mg OD	Azienda Ospedaliero Universitaria Maggiore della Carita, Abbott Medical Devices	Left Atrial Appendage Occlusion, Antiplatelet Therapy	12/23	12/23
NCT06275113: BRING-UP Prevention	Recruiting	N/A	6000	Europe		Heart Care Foundation	Ischemic Heart Disease, Cerebrovascular Disorders, Peripheral Arterial Disease	06/26	06/26
BRING-UP3HF, NCT06279988: BRING-UP 3 Heart Failure	Recruiting	N/A	10000	Europe		Heart Care Foundation	Heart Failure	06/26	07/26
AT-TARGET-IT, NCT05430828: Evaluation of Adherence, Persistence and Efficacy of Treatment With PCSK9 Inhibitors in Italy	Recruiting	N/A	2000	Europe	Repatha (evolocumab); Praluent (alirocumab)	Federico II University	Hypercholesterolemia	03/24	03/24